Researchers based in Manchester, UK, are working to make prescribing of medication safer for people in prison
The researchers searched electronic health records to uncover how many people in prisons have been affected by a potential problem related to their prescribed medication.
The team worked with prison pharmacists who conducted searches of the electronic healthcare records of two large prisons to identify how often people were affected by 13 ‘Prescribing Safety Indicators’ (PSIs). For example, prescribing of antipsychotic medication without carrying out the essential physical health tests to monitor weight, blood sugar and cholesterol.
To develop the PSIs researchers looked at published studies and worked with prison healthcare staff to identify the common situations where potentially hazardous prescribing can occur.
The results of the study revealed that more patients were affected by some PSIs than others. Understanding how the searches could be used more widely in prisons was also investigated with researchers interviewing 20 prison health care staff to explore this topic.
The staff they spoke to said that having people who can take on the leadership of the searches and working together as a team to respond to them was important.
The research was funded by Greater Manchester Mental Health NHS Foundation Trust (GMMH) Research Capability Funding and the National Institute for Health Research Greater Manchester Patient Safety Translational Research Centre (NIHR GM PSTRC). The Centre is a partnership between The University of Manchester and The Northern Care Alliance NHS Foundation Trust.
Prof Darren Ashcroft, director of the NIHR Greater Manchester PSTRC, said: “Our next step is to use these results to launch a new study.
“We are now working with a prison health care provider to test the introduction of the electronic health record searches and a way for staff to work together to respond to them across a large group of prisons nationally.
“This will take place over the next 18-24 months to see how effective this is at improving medication safety.”
The findings were published in the British Journal of Clinical Pharmacology.
